Unknown

Dataset Information

0

Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells.


ABSTRACT: Drug-eluting stents (DES) have reduced in-stent-restenosis drastically. Yet, the stent surface material directly interacts with cascades of biological processes leading to an activation of cellular defense mechanisms. To prevent adverse clinical implications, to date almost every patient with a coronary artery disease is treated with statins. Besides their clinical benefit, statins exert a number of pleiotropic effects on endothelial cells (ECs). Since maintenance of EC function and reduction of uncontrolled smooth muscle cell (SMC) proliferation represents a challenge for new generation DES, we investigated the effect of atorvastatin (ATOR) on human coronary artery cells grown on biodegradable polymers. Our results show a cell type-dependent effect of ATOR on ECs and SMCs. We observed polymer-dependent changes in IC50 values and an altered ATOR-uptake leading to an attenuation of statin-mediated effects on SMC growth. We conclude that the selected biodegradable polymers negatively influence the anti-proliferative effect of ATOR on SMCs. Hence, the process of developing new polymers for DES coating should involve the characterization of material-related changes in mechanisms of drug actions.

SUBMITTER: Strohbach A 

PROVIDER: S-EPMC4783882 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells.

Strohbach Anne A   Begunk Robert R   Petersen Svea S   Felix Stephan B SB   Sternberg Katrin K   Busch Raila R  

International journal of molecular sciences 20160122 2


Drug-eluting stents (DES) have reduced in-stent-restenosis drastically. Yet, the stent surface material directly interacts with cascades of biological processes leading to an activation of cellular defense mechanisms. To prevent adverse clinical implications, to date almost every patient with a coronary artery disease is treated with statins. Besides their clinical benefit, statins exert a number of pleiotropic effects on endothelial cells (ECs). Since maintenance of EC function and reduction of  ...[more]

Similar Datasets

| S-EPMC3833422 | biostudies-literature
| S-EPMC5438125 | biostudies-literature
2005-06-30 | GSE2143 | GEO
2022-08-11 | PXD013643 | Pride
2016-10-03 | GSE62281 | GEO
2019-05-15 | GSE118297 | GEO
| S-EPMC2700919 | biostudies-literature
| S-EPMC2784176 | biostudies-literature
2016-10-03 | GSE64860 | GEO
| PRJNA485132 | ENA